Delay HCV antivirals after liver transplant, study says

07/14/2010 | Medscape (free registration)

Researchers said hepatitis C patients who have had liver transplants should not start antiviral therapy for one year after surgery unless there is a resurgence of the HCV infection. The study found prophylactic antivirals had no effect on patient or graft survival and were poorly tolerated.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ